David Ohayon

TrioMed Innovations Corp. is a company dedicated to developing novel, antimicrobial technologies and products that help prevent the spread of infections and disease. Successor to Triosyn Corp. which was founded in 1992, the company has developed the 'TrioMed Technologies' creating innovative products such as the wound dressing incorporating unique antimicrobial properties and the next-generation in respirator and surgical facemask: the SafeLife B100 N95 Respirator (NIOSH-certified and U.S FDA-cleared). With more than 100 patents and patents pending, the scientific team and engineering groups have successfully harnessed the power of an iodinated resin novel molecular structure providing a non-toxic and more powerful antimicrobial efficacy based on the use of Tri-iodide. TrioMed has garnered regulatory approvals, licenses, clearances and certifications from the Environmental Protection Agency (EPA), Food & Drug Administration (FDA), National Institute for Occupational Safety and Health (NIOSH), INSPEC (EU) and Health Canada. Headquartered in Vermont U.S.A, the company includes manufacturing facilities and technological centers in both Vermont and Mirabel QC, Canada.

Safe Life Corp. develops antimicrobial technology. The company was founded in 2006 and is headquartered in La Jolla, CA.

KLOX Technologies, Inc. designs and develops therapeutic and cosmetic products. The firm offers fluorescence biomodulation technology. The company was founded by Francesco Bellini in 2007 and is headquartered in Laval, Canada.